FlyBase Allele Report: Scer\GAL4[GMR.PY]

General Information

Symbol

Scer\GAL4^GMR.PY

Species

S. cerevisiae

Name

glass multimer reporter construct of Yamada

FlyBase ID

FBal0152222

Feature type

allele

Associated gene

Scer\GAL4

Associated Insertion(s)

Carried in Construct

P{GMR-GAL4.Y}

Also Known As

GMR-GAL4, GBS-GAL4

Transgenic product class

Mutagen

in vitro construct

Nature of the Allele

Transgenic product class

Mutagen

in vitro construct

(Yamada et al., 2003)

Progenitor genotype

Carried in construct

P{GMR-GAL4.Y}

Cytology

Description

GMR regulatory sequences regulate expression of a GAL4 driver.

(Yamada et al., 2003)

Allele components

Component

Use(s)

Regulatory region(s)

GMR

engineered transcription regulatory region

Encoded product / tool

GAL4

binary expression system - driver

Mutations Mapped to the Genome

Curation Data

Type

Location

Additional Notes

References

Variant Molecular Consequences

Associated Sequence Data

DDBJ / EMBL / GenBank

DNA sequence

Protein sequence

UniProtKB/Swiss-Prot

UniProtKB/TrEMBL

Expression Data

Reporter Expression

distribution deduced from reporter (Gal4 UAS)

Stage

Tissue/Position (including subcellular localization)

Reference

third instar larval stage

eye disc

(Kouzmenko et al., 2004, Takeyama et al., 2002)

eye photoreceptor cell

(Takeyama et al., 2002)

pigment cell

(Takeyama et al., 2002)

retina

(Kouzmenko et al., 2004)

eye disc posterior to the morphogenetic furrow

(Yamada et al., 2003)

electron microscopy

Stage

Tissue/Position (including subcellular localization)

Reference

eye

(Kohyama-Koganeya et al., 2004)

Additional Information

Statement

Reference

Drives expression in cells of the eye disc posterior to the morphogenetic furrow, including eye photoreceptor cells.

(FlyBase Curators, 2017)

Marker for

embryonic/larval optic stalk

(Murakami et al., 2007)

eye

(Kohyama-Koganeya et al., 2004)

eye disc posterior to the morphogenetic furrow

(Yamada et al., 2003)

eye photoreceptor cell

(Murakami et al., 2007, Takeyama et al., 2002)

pigment cell

(Takeyama et al., 2002)

Reflects expression of

Reporter construct used in assay

Human Disease Associations

Disease Ontology (DO) Annotations

Models Based on Experimental Evidence ( 0 )

Disease

Evidence

References

Modifiers Based on Experimental Evidence ( 0 )

Disease

Interaction

References

Comments on Models/Modifiers Based on Experimental Evidence ( 0 )

Disease-implicated variant(s)

Phenotypic Data

Phenotypic Class

abnormal eye color | adult stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

abnormal neuroanatomy | adult stage, with caps^UAS.cSa

(Shinza-Kameda et al., 2006)

abnormal neuroanatomy | larval stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

abnormal neurophysiology | adult stage, with Dbct^KK102355

(Tsai et al., 2020)

decreased size | adult stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

increased cell death, with arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

increased cell death, with Hsap\ESR1^UAS.cKa

(Kouzmenko et al., 2004)

increased cell death, with X11L^UAS.cMa

(Hase et al., 2002)

increased cell death | larval stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

increased cell death | larval stage, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

melanotic necrosis | adult stage, with SARS-CoV-2\nsp3^UAS.Tag:HA

(Singh et al., 2024)

melanotic necrosis | adult stage | progressive, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

visible, with arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

visible, with Hsap\APBA2^UAS.cHa

(Hase et al., 2002)

visible, with Hsap\AR^AF-1.UAS

(Takeyama et al., 2002)

visible, with Hsap\AR^Q52AF-1.UAS

(Takeyama et al., 2002)

visible, with Hsap\ESR1^UAS.cKa

(Kouzmenko et al., 2004)

visible, with tinc^RNAi.UAS

(Hirota et al., 2005)

visible, with tinc^UAS.cHa

(Hirota et al., 2005)

visible, with X11L^C.UAS

(Hase et al., 2002)

visible, with X11L^PI+C.UAS

(Hase et al., 2002)

visible, with X11L^UAS.cMa

(Hase et al., 2002)

visible, with Zzzz\CAG^{127Q.UAS.Tag:HA}

(Takeyama et al., 2002)

visible | adult stage, with SARS-CoV-2\nsp2^UAS.cZa

(Singh et al., 2024)

visible | adult stage, with SARS-CoV-2\nsp2^UAS.Tag:HA

(Singh et al., 2024)

visible | adult stage, with SARS-CoV-2\nsp3^UAS.Tag:HA

(Singh et al., 2024)

visible | adult stage, with SARS-CoV-2\ORF6^UAS.cZa

(Singh et al., 2024)

visible | adult stage, with SARS-CoV-2\ORF6^UAS.Tag:HA

(Singh et al., 2024)

visible | adult stage, with Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

visible | adult stage | progressive, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

visible | drug conditional, with Hsap\AR^Q52.UAS

(Takeyama et al., 2002)

Phenotype Manifest In

cone cell, with tinc^RNAi.UAS

(Hirota et al., 2005)

eye, with arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

eye, with Hsap\APBA2^UAS.cHa

(Hase et al., 2002)

eye, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

eye, with Hsap\AR^AF-1.UAS

(Takeyama et al., 2002)

eye, with Hsap\AR^Q52AF-1.UAS

(Takeyama et al., 2002)

eye, with Hsap\ESR1^UAS.cKa

(Kouzmenko et al., 2004)

eye, with SARS-CoV-2\nsp2^UAS.cZa

(Singh et al., 2024)

eye, with SARS-CoV-2\nsp2^UAS.Tag:HA

(Singh et al., 2024)

eye, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

eye, with SARS-CoV-2\nsp3^UAS.Tag:HA

(Singh et al., 2024)

eye, with SARS-CoV-2\ORF6^UAS.cZa

(Singh et al., 2024)

eye, with SARS-CoV-2\ORF6^UAS.Tag:HA

(Singh et al., 2024)

eye, with X11L^C.UAS

(Hase et al., 2002)

eye, with X11L^PI+C.UAS

(Hase et al., 2002)

eye, with X11L^UAS.cMa

(Hase et al., 2002)

eye, with Zzzz\CAG^{127Q.UAS.Tag:HA}

(Takeyama et al., 2002)

eye, with Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

eye | drug conditional, with Hsap\AR^Q52.UAS

(Takeyama et al., 2002)

eye disc, with arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

eye disc, with Hsap\ESR1^UAS.cKa

(Kouzmenko et al., 2004)

eye disc, with X11L^UAS.cMa

(Hase et al., 2002)

eye disc | larval stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

eye disc | larval stage, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

eye photoreceptor cell, with tinc^RNAi.UAS

(Hirota et al., 2005)

eye photoreceptor cell, with tinc^UAS.cHa

(Hirota et al., 2005)

eye photoreceptor cell | larval stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

ommatidium, with Hsap\AR^AF-1.UAS

(Takeyama et al., 2002)

ommatidium, with Hsap\AR^Q52AF-1.UAS

(Takeyama et al., 2002)

ommatidium, with tinc^RNAi.UAS

(Hirota et al., 2005)

ommatidium, with tinc^UAS.cHa

(Hirota et al., 2005)

ommatidium, with Zzzz\CAG^{127Q.UAS.Tag:HA}

(Takeyama et al., 2002)

ommatidium | adult stage, with Hsap\APP^{Aβ42.UAS.cUa}

(Singh et al., 2024)

ommatidium | adult stage, with pk^KK109294, pk^sple-1

(Cho et al., 2022)

ommatidium | adult stage, with SARS-CoV-2\nsp3^UAS.cZa

(Singh et al., 2024)

ommatidium | drug conditional, with Hsap\AR^Q52.UAS

(Takeyama et al., 2002)

photoreceptor cell R7, with caps^UAS.cSa

(Shinza-Kameda et al., 2006)

pigment cell, with tinc^RNAi.UAS

(Hirota et al., 2005)

primary pigment cell, with tinc^RNAi.UAS

(Hirota et al., 2005)

retina | adult stage, with Dbct^KK102355

(Tsai et al., 2020)

retina | drug conditional, with Hsap\AR^Q52.UAS

(Takeyama et al., 2002)

rhabdomere of eye photoreceptor cell | adult stage | decreased number, with Dbct^KK102355

(Tsai et al., 2020)

Detailed Description

Statement

Reference

External Data

Linkouts

Interactions

Show genetic interaction network for Enhancers & Suppressors

Phenotypic Class

Enhanced by

Statement

Reference

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has visible | adult stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has abnormal neuroanatomy | larval stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has decreased size | adult stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has increased cell death | larval stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has visible | adult stage phenotype, enhanceable by Otud6^C183A/Otud6[+]

(Villa et al., 2024)

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has visible | adult stage phenotype, enhanceable by Otud6^KK105705, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY has visible phenotype, enhanceable by arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY has increased cell death phenotype, enhanceable by arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)} has visible phenotype, enhanceable by Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)} has increased cell death phenotype, enhanceable by Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

NOT Enhanced by

Statement

Reference

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has visible | adult stage phenotype, non-enhanceable by Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Suppressed by

Statement

Reference

Hsap\AR^Q52.UAS, Scer\GAL4^GMR.PY has visible phenotype, suppressible | drug conditional | partially by DnaJ-1^UAS.cKa, Scer\GAL4^GMR.PY

(Takeyama et al., 2002)

NOT suppressed by

Statement

Reference

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has visible | adult stage phenotype, non-suppressible by Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Enhancer of

Statement

Reference

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of visible | adult stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of abnormal neuroanatomy | larval stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of decreased size | adult stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of increased cell death | larval stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Otud6^KK105705, Scer\GAL4^GMR.PY is an enhancer of visible | adult stage phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY is an enhancer of visible phenotype of Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY is an enhancer of increased cell death phenotype of Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY is an enhancer of visible phenotype of Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY is an enhancer of increased cell death phenotype of Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

NOT Enhancer of

Statement

Reference

Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY is a non-enhancer of visible | adult stage phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

Suppressor of

Statement

Reference

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a suppressor of visible phenotype of grim^GMR.PA

(Kohyama-Koganeya et al., 2004)

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a suppressor of visible phenotype of rpr^GMR.PA

(Kohyama-Koganeya et al., 2004)

DnaJ-1^UAS.cKa, Scer\GAL4^GMR.PY is a suppressor | drug conditional | partially of visible phenotype of Hsap\AR^Q52.UAS, Scer\GAL4^GMR.PY

(Takeyama et al., 2002)

NOT Suppressor of

Statement

Reference

Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY is a non-suppressor of visible | adult stage phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a non-suppressor of visible phenotype of hid^GMR.PA

(Kohyama-Koganeya et al., 2004)

Phenotype Manifest In

Enhanced by

Statement

Reference

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has eye phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has eye photoreceptor cell | larval stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY has eye disc | larval stage phenotype, enhanceable by SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has eye phenotype, enhanceable by Otud6^C183A/Otud6[+]

(Villa et al., 2024)

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has eye phenotype, enhanceable by Otud6^KK105705, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)} has eye disc phenotype, enhanceable by Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY has eye phenotype, enhanceable by arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)} has eye phenotype, enhanceable by Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY has eye disc phenotype, enhanceable by arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

NOT Enhanced by

Statement

Reference

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has eye phenotype, non-enhanceable by Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Suppressed by

Statement

Reference

Hsap\AR^Q52.UAS, Scer\GAL4^GMR.PY has eye phenotype, suppressible | drug conditional | partially by DnaJ-1^UAS.cKa, Scer\GAL4^GMR.PY

(Takeyama et al., 2002)

NOT suppressed by

Statement

Reference

Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS has eye phenotype, non-suppressible by Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY

(Villa et al., 2024)

Enhancer of

Statement

Reference

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of eye phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of eye photoreceptor cell | larval stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

SARS-CoV-2\nsp3^UAS.cZa, Scer\GAL4^GMR.PY is an enhancer of eye disc | larval stage phenotype of Hsap\APP^{Aβ42.UAS.cUa}, Scer\GAL4^GMR.PY

(Singh et al., 2024)

Otud6^KK105705, Scer\GAL4^GMR.PY is an enhancer of eye phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY is an enhancer of eye disc phenotype of Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY is an enhancer of eye phenotype of Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY is an enhancer of eye phenotype of Scer\GAL4^GMR.PY, arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}

(Kouzmenko et al., 2004)

arm^{ΔN.UAS.Tag:HA,Tag:Myr(Unk)}, Scer\GAL4^GMR.PY is an enhancer of eye disc phenotype of Hsap\ESR1^UAS.cKa, Scer\GAL4^GMR.PY

(Kouzmenko et al., 2004)

NOT Enhancer of

Statement

Reference

Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY is a non-enhancer of eye phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

Suppressor of

Statement

Reference

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a suppressor of eye phenotype of grim^GMR.PA

(Kohyama-Koganeya et al., 2004)

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a suppressor of eye phenotype of rpr^GMR.PA

(Kohyama-Koganeya et al., 2004)

DnaJ-1^UAS.cKa, Scer\GAL4^GMR.PY is a suppressor | drug conditional | partially of eye phenotype of Hsap\AR^Q52.UAS, Scer\GAL4^GMR.PY

(Takeyama et al., 2002)

NOT Suppressor of

Statement

Reference

Otud6^{UAS.Tag:FLAG,Tag:HA}, Scer\GAL4^GMR.PY is a non-suppressor of eye phenotype of Scer\GAL4^GMR.PY, Zzzz\poly-GR^PO-36.UAS

(Villa et al., 2024)

GlcT^UAS.cKa/Scer\GAL4^GMR.PY is a non-suppressor of eye phenotype of hid^GMR.PA

(Kohyama-Koganeya et al., 2004)

Additional Comments

Genetic Interactions

Statement

Reference

Xenogenetic Interactions

Statement

Reference

Complementation and Rescue Data

Rescues

tinc^UAS.cHa/Scer\GAL4^GMR.PY rescues tinc^RNAi.UAS

(Hirota et al., 2005)

Partially rescues

Vang^UAS.cLa/Scer\GAL4^GMR.PY partially rescues Vang^stbm-6/Vang^A3

(Cho et al., 2022)

Hsap\AR^AF-2.UAS/Scer\GAL4^GMR.PY partially rescues Hsap\AR^Q52AF-1.UAS

(Takeyama et al., 2002)

Fails to rescue

Fak^UAS.Tag:HA/Scer\GAL4^GMR.PY fails to rescue Fak^CG1

(Murakami et al., 2007)

Comments

Images (0)

Mutant

Wild-type

Stocks (1)

Bloomington

84247

w^*; P{GMR-GAL4.Y}YH3/TM3, Sb¹

Notes on Origin

Discoverer

External Crossreferences and Linkouts ( 0 )

Synonyms and Secondary IDs (3)

Reported As

Symbol Synonym

GBS-GAL4

(Hirota et al., 2005)

Scer\GAL4^GMR.PY

Name Synonyms

glass multimer reporter construct of Yamada

(Yamada et al., 2003)

Secondary FlyBase IDs

References (25)

Report Sections

Open Close